Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer
NCT03793205Phase 4Unknown
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial in febrile neutropenia (FN) and chemotherapy-induced neutropenia (CIN) (2 arms). Primary endpoint: Incidence of febrile neutropenia at 1 year. Status: unknown.
02
Conditions
febrile neutropenia (FN)chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT03793205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03793205.